| 000 | 01822 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513200759.0 | ||
| 264 | 0 | _c20000110 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0028-2685 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFilip, S | |
| 245 | 0 | 0 |
_aThe increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients. _h[electronic resource] |
| 260 |
_bNeoplasma _c1999 |
||
| 300 |
_a166-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aErythropoietin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadverse effects |
| 650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Mobilization |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukapheresis |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aVanásek, J | |
| 700 | 1 | _aBláha, M | |
| 700 | 1 | _aMericka, P | |
| 700 | 1 | _aVávrová, J | |
| 700 | 1 | _aPodzimek, K | |
| 773 | 0 |
_tNeoplasma _gvol. 46 _gno. 3 _gp. 166-72 |
|
| 999 |
_c10569310 _d10569310 |
||